---
schema_version: "secwatch.filing_event.v1"
accession: "0001964738-24-000040"
form_type: "8-K"
ticker: "SOLV"
cik: "0001964738"
company_name: "Solventum Corp"
filed_at: "2024-11-07T23:59:59+00:00"
generated_at: "2026-05-30T03:57:40.089595+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Solventum Q3 sales flat at $2.082B; adjusted EPS $1.64, raises FY guidance

## Summary
- GAAP EPS $0.70, adjusted EPS $1.64; operating income $275M GAAP, $475M adjusted.
- Reported sales +0.4% YoY; organic sales +0.3%; MedSurg and HIS led growth.
- Free cash flow $76M; cash from operations $169M.
- Full-year organic sales growth, adjusted EPS, and free cash flow guidance raised.
- CEO cites consecutive outperformance; supply agreement mark-up impacted margins.

## SEC filing metadata
- accession: 0001964738-24-000040
- form_type: 8-K
- ticker: SOLV
- cik: 0001964738
- company_name: Solventum Corp
- filed_at: 2024-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1964738/000196473824000040/0001964738-24-000040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1964738/000196473824000040/solv-20241107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001964738-24-000040
- JSON: https://secwatch.observer/filing/0001964738-24-000040.json
- Plain text: https://secwatch.observer/filing/0001964738-24-000040.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.